Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05185245

Liver Transplantation for Non-Resectable Colorectal Liver Metastasis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
Sex
All
Age
18 Years – 73 Years
Healthy volunteers
Not accepted

Summary

The study aims to evaluate the efficacy of liver transplantation in the context of non-resectable colorectal liver metastasis. The primary endpoint is the overall survival in this group of patients while the secondary endpoint is the disease-free survival. Patients included in this protocol will be evaluated either for whole or partial liver transplantation from deceased or living donors. Type of different transplantations proposed are as follows: 1. Whole liver graft or partial liver (split) from a deceased donor 2. Partial liver graft retrieved from a deceased donor and orthotopically implanted after having performed a left hepatectomy in the recipient. 3. Partial liver graft retrieved from a deceased donor and heterotopically implanted if total hepatectomy can not be performed. 4. Partial liver graft retrieved from a living donor and orthotopically implanted after having performed total hepatectomy. 5. Partial liver graft retrieved from a living donor and orthotopically implanted after having after having performed a left hepatectomy in the recipient. 6. Partial liver graft retrieved from a living donor and heterotopically implanted if total hepatectomy can not be performed. In cases 2-3-5-6 total hepatectomy of native liver can be secondarily performed after having achieved a proper graft hypertrophy in order to avoid a small for size syndrome

Conditions

Interventions

TypeNameDescription
PROCEDURELiver TransplantationLiver Transplantation for Non-Resectable Colorectal Liver Metastasis

Timeline

Start date
2021-04-01
Primary completion
2025-03-30
Completion
2030-03-30
First posted
2022-01-11
Last updated
2022-01-11

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05185245. Inclusion in this directory is not an endorsement.